Investing
Also: Truepill to expand digital pharmacy business with $25 million Series B; Nucleai's precision oncology platform gains $6.5 million from Debiopharm.
Like its competitors, the telehealth provider highlighted a major increase in business since COVID-19.
FraudScope, an artificial intelligence platform that detects heatlhcare fraud, waste and abuse, completed a $7 million Series A round of funding last week.
Telehealth and digital behavioral health were two of the most popular investment areas.
Also: NexHealth's $15 million Series A, Avive Solutions' $7 million raise and Cyclica's $16.9 million Series B.
This latest contribution was led by Mubadala Capital and Bpifrance.
Alphabet, General Catalyst, Kholsa Ventures, Lakestar, Thrive Capital and Baillie Gifford participated in this round.
DispatchHealth, an in-home care provider, closed its $135.
The company also announced a $5.1 million seed funding led by Forerunner Ventures.
The new round led by Andreessen Horowitz will be put towards expanding the company's growth.